Predicting US- and state-level cancer counts for the current calendar year: Part II: Evaluation of spatiotemporal projection methods for incidence

Cancer

Volumn 118, Issue 4, 2012, Pages 1100-1109

  Zhu, Li ^a   Pickle, Linda W ^b   Ghosh, Kaushik ^c   Naishadham, Deepa ^d   Portier, Kenneth ^d   Chen, Huann Sheng ^a   Kim, Hyune Ju ^e   Zou, Zhaohui ^f   Cucinelli, James ^f   Kohler, Betsy ^g   Edwards, Brenda K ^a   King, Jessica ^h   Feuer, Eric J ^a   Jemal, Ahmedin ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b StatNet Consulting LLC   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d AMERICAN CANCER SOCIETY   (United States)

^e SYRACUSE UNIVERSITY   (United States)

^f INFORMATION MANAGEMENT SERVICES INC   (United States)

^g North American Association of Central Cancer Registries   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cancer incidence; cancer surveillance; National Program of Cancer Registries (NPCR); projection methods; spatiotemporal; Surveillance, Epidemiology, and End Results (SEER)

Indexed keywords

ACCURACY; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER STATISTICS; CHILD; CONTROLLED STUDY; DATA ANALYSIS; EVALUATION RESEARCH; FEMALE; HUMAN; INFANT; MALE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SEX RATIO; TREND STUDY; TUMOR LOCALIZATION; UNITED STATES; VALIDATION PROCESS; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ANUS CANCER; BLADDER CANCER; BONE CANCER; BRAIN CANCER; BREAST CANCER; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLON CANCER; DIGESTIVE SYSTEM CANCER; ENDOCRINE TUMOR; ESOPHAGUS CANCER; EYE CANCER; GALLBLADDER CANCER; HODGKIN DISEASE; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MELANOMA; MOUTH CANCER; MYELOMA; NEOPLASM; NEWBORN; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PENIS CANCER; PHARYNX CANCER; PROSTATE CANCER; RECTUM CANCER; RESPIRATORY TRACT CANCER; SKIN CANCER; SMALL INTESTINE CANCER; SOFT TISSUE CANCER; SPATIOTEMPORAL ANALYSIS; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; TONGUE CANCER; URETER CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA CANCER; VULVA CANCER;

AMERICAN CANCER SOCIETY; FEMALE; FORECASTING; HUMANS; INCIDENCE; MALE; MODELS, STATISTICAL; NEOPLASMS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; UNITED STATES;

EID: 84856774263     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27405     Document Type: Article

References (28)

1. Siegel R, Ward E, Brawley O, Jemal A,. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61: 212-236.
2. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF,. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002; 94: 1537-1545.
3. American Cancer Society. Cancer Facts & Figures 1953. New York: American Cancer Society; 1953.
4. American Cancer Society. Cancer Facts & Figures 1961. New York: American Cancer Society; 1961.
5. National Cancer Institute. Surveillance, Epidemiology, and End Results. Accessed October 11, 2011.
6. Wingo P, Landis S, Parker S, Bolden S, Heath CWJ,. Using cancer registry and vital statistics data to estimate the number of new cancer cases and deaths in the United States for the upcoming year. J Registry Manag. 1998; 25: 43-51.
7. Pickle LW, Hao Y, Jemal A, et al. A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin. 2007; 57: 30-42.
8. North American Association of Central Cancer Registries. Who is Certified. Accessed August 25, 2011.
9. National Cancer Institute. Surveillance, Epidemiology, and End Results 9 Delay Model. Accessed August 25, 2011.
10. National Cancer Institute Cancer Counts Prediction Workgroup. Technical Details of Predicting US and State-Level Cancer Counts for the Current Calendar Year. Accessed December 15, 2011.
11. North American Association of Central Cancer Registries. CINA Deluxe Analytic File. Accessed August 25, 2011.
12. National Cancer Institute. Surveillance, Epidemiology, and End Results. Population Estimates Used in NCI's SEER Stat Software. Accessed August 25, 2011.
13. Health Resources and Services Administration. Area Resource File. Accessed December 19, 2011.
14. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Survey Data and Documentation. Accessed August 25, 2011.
15. Centers for Disease Control and Prevention. National Vital Statistics System. Mortality Data. Accessed August 25, 2011.
16. Centers for Disease Control and Prevention. National Program of Cancer Registries (NPCR). Accessed October 11, 2011.
17. Kim HJ, Fay MP, Feuer EJ, Midthune DN,. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335-351.
18. National Cancer Institute. Joinpoint Regression Program. Latest Release: Version 3.5.2. Accessed August 25, 2011.
19. Moller B, Fekjaer H, Hakulinen T, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003; 22: 2751-2766.
20. Holford TR,. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983; 39: 311-324.
21. Tiwari RC, Ghosh K, Jemal A, et al. A new method of predicting US and state-level cancer mortality counts for the current calendar year. CA Cancer J Clin. 2004; 54: 30-40.
22. Venables WN, Smith DM, R Development Core Team. An Introduction to R. Notes on R: A Programming Environment for Data Analysis and Graphics, Version 2.13.2. Vol 2011-09-30. Accessed October 11, 2011.
23. Huang NE, Shen Z, Long SR, et al. The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysis. Proc R Soc Lond A. 1998; 454: 903-995.
24. American Cancer Society. Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society; 2007.
25. Olsen AH, Parkin DM, Sasieni P,. Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer. 2008; 99: 1549-1554.
26. Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS,. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control. 1998; 9: 519-527.
27. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007; 356: 1670-1674.
28. Biner S, Perk G, Kar S, et al. Utility of combined two-dimensional and three-dimensional transesophageal imaging for catheter-based mitral valve clip repair of mitral regurgitation. J Am Soc Echocardiogr. 2011; 24: 611-617.